// App-Quantinova.ai

: Real‐world Study of Physician Practice Patterns, Efficacy and Safety of Human Cell Line‐derived Recombinant Factor VIII in Adults with Hemophilia A

Researchers

Presenter

  • H. Sun

Principal Investigators

  • B. Ritchie

  • J. Petrucci

  • J. Teitel

  • M. Sholzberg

Medical Centers

  • University of Alberta, Division of Hematology, Department of Medicine, Edmonton, AB, Canada

  • St. Michael's Hospital, Hematology‐Oncology Clinical Reserach Group, Toronto, Canada

  • St. Michael's Hospital / University of Toronto, Department of Medicine, Toronto, Canada

  • St. Michael's Hospital, University of Toronto, Departments of Medicine and Laboratory Medicine & Pathobiology, Toronto, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

Disease

  • Hemophilia

  • Tuberculosis

Biomarkers

  • N/A

Drug/Treatment

  • Recombinant Factor VIII

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved